+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

Plaque Psoriasis: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Plaque Psoriasis: 68-Market Analysis and Sales Forecast

  • Report
  • July 2024
  • 19 Pages
  • Global
From
Methoxsalen (CAS 298-81-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Methoxsalen (CAS 298-81-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • March 2025
  • 50 Pages
  • Global
From
Methotrexate (CAS 59-05-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Methotrexate (CAS 59-05-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • March 2025
  • 50 Pages
  • Global
From
Hydrocortisone (CAS 50-23-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Hydrocortisone (CAS 50-23-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • March 2025
  • 50 Pages
  • Global
From
HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships - Product Thumbnail Image

HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships

  • Report
  • July 2021
  • Global
From
Ustekinumab (Stelara) Biosimilars Pipeline Review - Product Thumbnail Image

Ustekinumab (Stelara) Biosimilars Pipeline Review

  • Report
  • March 2025
  • Global
From
Adalimumab (Humira) Biosimilars Pipeline Review - Product Thumbnail Image

Adalimumab (Humira) Biosimilars Pipeline Review

  • Report
  • March 2025
  • Global
From
Investigation Report on China's Infliximab Market 2022-2031 - Product Thumbnail Image

Investigation Report on China's Infliximab Market 2022-2031

  • Report
  • July 2022
  • 40 Pages
  • China
From
Investigation Report on China's Ustekinumab Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Ustekinumab Market 2021-2025

  • Report
  • May 2021
  • 50 Pages
  • China
From
Investigation Report on China's Adalimumab Market, 2021-2025 - Product Thumbnail Image

Investigation Report on China's Adalimumab Market, 2021-2025

  • Report
  • April 2021
  • 40 Pages
  • China
From
Psoriasis Global Market Report 2024 - Product Thumbnail Image

Psoriasis Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Coal Tar Topical Solution Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030 - Product Thumbnail Image

Coal Tar Topical Solution Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030

  • Report
  • September 2023
  • 146 Pages
  • Global
From
Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
US HUMIRA Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

US HUMIRA Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • United States
Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Vitamin D Receptor (VDR or Calcitriol Receptor) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
REMICADE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SKYRIZI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SKYRIZI Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
HUMIRA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

HUMIRA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
STELARA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

STELARA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more